WPI 2266 (Acitretin 25 mg)
Pill with imprint WPI 2266 is Brown & Yellow, Capsule-shape and has been identified as Acitretin 25 mg. It is supplied by Actavis Pharma, Inc.
Acitretin is used in the treatment of psoriasis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2266
Acitretin
- Imprint
- WPI 2266
- Strength
- 25 mg
- Color
- Brown & Yellow
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antipsoriatics
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2266 (Discontinued)
- Inactive Ingredients
-
maltodextrin,
sodium ascorbate,
microcrystalline cellulose,
gelatin,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
shellac,
ferrosoferric oxide,
propylene glycol
Note: Inactive ingredients may vary.
More about acitretin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (34)
- Drug images
- Pricing & coupons
- En español
- Drug class: antipsoriatics
Patient resources
- Other brands
- Soriatane
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.